Generated by GPT-5-mini| Eric Nestler | |
|---|---|
| Name | Eric Nestler |
| Birth date | 1947 |
| Birth place | New York City |
| Occupation | Neuroscientist, Professor |
| Employer | Icahn School of Medicine at Mount Sinai |
| Alma mater | Harvard College; Yale University School of Medicine |
Eric Nestler
Eric Nestler is an American neuroscientist and physician known for work on molecular mechanisms of addiction, depression, and stress-related psychiatric disorders. He has held leadership roles at the Icahn School of Medicine at Mount Sinai, influenced translational neuroscience linking molecular pathways to behavior, and collaborated with investigators across institutions studying transcriptional and epigenetic regulation in the brain.
Nestler was born in New York City and attended Harvard College for undergraduate study, where he studied biochemistry and related subjects before matriculating at Yale University School of Medicine for his medical degree. He completed residency training and clinical fellowships at affiliated hospitals associated with Yale-New Haven Hospital and pursued research training at National Institutes of Health programs and laboratory mentorships linked to investigators at Harvard Medical School and Columbia University Vagelos College of Physicians and Surgeons.
Nestler joined the faculty of the Yale School of Medicine faculty and later took appointments at the Mount Sinai School of Medicine, which became the Icahn School of Medicine at Mount Sinai. He served as Director of the Friedman Brain Institute and has held the Nash Family Professor of Neuroscience chair at Mount Sinai. His career has intersected with colleagues at the Broad Institute of MIT and Harvard, Stanford University School of Medicine, University of California, San Francisco, and international centers including University College London and the Max Planck Society. He has been involved with funding and policy organizations such as the National Institute on Drug Abuse, the National Institute of Mental Health, and the Brain & Behavior Research Foundation.
Nestler’s research has elucidated molecular adaptations in reward circuitry, stress response systems, and transcriptional control that underlie addiction and depression. He identified roles for signaling pathways including cyclic AMP response element-binding protein (CREB) and ΔFosB in the nucleus accumbens and ventral tegmental area, connecting them to behavioral models used in studies at institutions such as Columbia University and University of Pennsylvania. His work emphasized chromatin remodeling, histone modification, and DNA methylation in neuronal plasticity, paralleling discoveries from laboratories at the Salk Institute and the Whitehead Institute. Collaborations and cross-references involve studies on synaptic plasticity mechanisms described by researchers at Cold Spring Harbor Laboratory, Johns Hopkins University School of Medicine, and Massachusetts Institute of Technology.
He advanced the concept that persistent transcriptional regulators act as molecular switches that stabilize long-term behavioral states, integrating findings on immediate early genes, neurotrophic factors like brain-derived neurotrophic factor (BDNF), and stress hormones tied to the hypothalamic–pituitary–adrenal axis. His group employed animal models—rodent paradigms used in labs at University of Cambridge and Yale University—and human postmortem brain studies coordinated with biobanks and consortia such as the PsychENCODE project. Techniques he adopted and refined include viral-mediated gene transfer, optogenetics aligned with tools developed at Princeton University and MIT, and genome-wide analyses comparable to methods from the European Molecular Biology Laboratory.
Nestler’s recognitions include election to the Institute of Medicine (now the National Academy of Medicine), awards from the Society for Neuroscience, and lifetime achievement honors from psychiatric research organizations such as the American College of Neuropsychopharmacology and the Brain & Behavior Research Foundation. He has received named lectureships associated with Cold Spring Harbor Laboratory, the Keystone Symposia, and the Gordon Research Conferences, and grant support through programs at the National Institutes of Health and foundations including the Simons Foundation.
Nestler has served on editorial boards for journals comparable to Nature Neuroscience, Neuron, and Journal of Neuroscience and advisory panels for governmental and philanthropic agencies such as the National Institute on Drug Abuse, the National Institute of Mental Health, the Robert Wood Johnson Foundation, and the Howard Hughes Medical Institute. He has chaired scientific committees at the Society for Neuroscience annual meeting and participated in consortium leadership for initiatives like the Brain Initiative and collaborative networks involving the Human Brain Project and international research councils.
- Nestler ER (author list includes collaborators from Yale University and Mount Sinai), studies on ΔFosB and addiction signaling in journals parallel to Science and Nature Medicine. - Reviews on epigenetic mechanisms in depression with colleagues affiliated with Harvard Medical School and Columbia University in publications resembling Nature Reviews Neuroscience. - Experimental papers on CREB function in reward pathways coauthored with investigators at Stanford University and University of California, San Diego published in venues comparable to Neuron. - Translational reports linking human postmortem studies and animal models in formats similar to Proceedings of the National Academy of Sciences.
Category:American neuroscientists